BlueCrest Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-84,381
| Closed | -$10.2M | – | 320 |
|
|
2023
Q1 | $10.2M | Buy |
84,381
+15,366
| +22% | +$1.86M | 0.33% | 24 |
|
|
2022
Q4 | $7.92M | Buy |
69,015
+55,925
| +427% | +$6.42M | 0.21% | 33 |
|
|
2022
Q3 | $1.33M | Buy |
+13,090
| New | +$1.33M | 0.04% | 94 |
|
|
2022
Q2 | – | Sell |
-33,302
| Closed | -$3.88M | – | 250 |
|
|
2022
Q1 | $3.88M | Sell |
33,302
-1,982
| -6% | -$231K | 0.13% | 84 |
|
|
2021
Q4 | $4.05M | Buy |
+35,284
| New | +$4.05M | 0.13% | 107 |
|
|
2020
Q3 | – | Sell |
-24,726
| Closed | -$2.59M | – | 329 |
|
|
2020
Q2 | $2.59M | Buy |
+24,726
| New | +$2.59M | 0.14% | 98 |
|